Breaking: Pfizer's RSV Vaccine Shows Promise - Shares Surge
MarketAlleys Desk
Published · Updated · 1 min read
Pfizer's stock surged 1.5% after its respiratory syncytial virus vaccine Abrysvo, showed positive results in a trial for high-risk adults under 60. It was also well tolerated, producing similar immune responses to those seen in older adults.
The trial enrolled 681 adults with conditions such as asthma and diabetes. Pfizer said it would seek expanded approval for adults 18 through 59 based on the findings. RSV is a common cause of pneumonia in toddlers and older adults. But experts are divided over the vaccine's clinical benefit for most people in both high-risk groups.
Revision history
- Published
- Last updated
Ask about this story
Questions are answered only from this article and the sources it cites.
MarketAlleys provides news and analysis for information only; it is not investment advice or a recommendation to buy or sell any security. Markets involve risk. Risk disclaimer.
Was this useful?
Report an issue with this article
Get the Daily Brief
What moved, why, and what matters next — every morning.
Related coverage
Banks and big tech headline an eight‑item earnings slate over the next three days
Eight high‑importance US earnings are scheduled over the next three days, led by a cluster of bank reports on Tuesday before the open and Bank of America and Morgan Stanley due Wednesday before the open.
MarketAlleys Research Desk · · 4 min read
JPMorgan After Meta Muse Hits Bank And Insurer Multiples
JPMorgan is not trading a slogan about too big to fail. It is trading a bank after a software agent from Meta hit the multiple on lenders and insurers in the same session. Financials were the weak sleeve while chips ran.
MarketAlleys Desk · · 2 min read
Coinbase After The Senate Blocks The Trump Backed Crypto Bill
Coinbase is not trading a slogan about digital assets. It is trading a listed exchange after the Senate refused to advance the comprehensive bill the White House wanted. That vote landed into a Federal Reserve week.
MarketAlleys Desk · · 2 min read
Lennar Into Benchmark Treasury Yields And Wednesday Housing Guidance
Lennar is not trading a slogan about the housing cycle. It is trading a builder that reports into a week when the long Treasury yield just cleared a level that last mattered years ago. Mortgage math follows that yield.
MarketAlleys Desk · · 2 min read